{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T09:18:52Z","timestamp":1794907132644,"version":"4.9.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"American Kratom Association"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.drugalcdep.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T01:01:06Z","timestamp":1494378066000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":294,"special_numbering":"C","title":["Patterns of Kratom use and health impact in the US\u2014Results from an online survey"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2302-8949","authenticated-orcid":false,"given":"Oliver","family":"Grundmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.15585\/mmwr.mm6529a4","article-title":"Notes from the field: Kratom (Mitragyna speciosa) exposures reported to poison centers\u2014United States, 2010\u20132015","volume":"65","author":"Anwar","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0010","series-title":"American Kratom Association. Personal Communication, Oliver Grundmann","author":"Ash","year":"2017"},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0015","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self-treatment of opioid withdrawal using Kratom (Mitragynia speciosa korth)","volume":"103","author":"Boyer","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0020","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.addbeh.2014.03.009","article-title":"Prevalence and characteristics of e-cigarette users in Great Britain: findings from a general population survey of smokers","volume":"39","author":"Brown","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0025","series-title":"Drug Enforcement Administration","article-title":"DEA announces intent to schedule kratom","author":"DEA","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0030","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From Kratom to mitragynine and its derivatives physiological and behavioural effects related to use, abuse, and addiction","volume":"37","author":"Hassan","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12576-014-0304-0","article-title":"Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats","volume":"64","author":"Hazim","year":"2014","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0040","series-title":"Assessment of Kratom Under the CSA Eight Factors and Scheduling Recommendations","author":"Henningfield","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.phymed.2010.08.011","article-title":"Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression","volume":"18","author":"Idayu","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0050","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1021\/jacs.6b00360","article-title":"Synthetic and receptor signaling explorations of the Mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators","volume":"138","author":"Kruegel","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: distinct roles in mood disorders","volume":"36","author":"Lutz","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0060","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.lfs.2003.09.054","article-title":"Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa","volume":"74","author":"Matsumoto","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/pme.12233","article-title":"Systematic literature review and meta-analysis of the efficacy and safety of prescription opioids including abuse-deterrent formulations, in non-cancer pain management","volume":"15","author":"Michna","year":"2014","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0070","first-page":"792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Prozialeck","year":"2012","journal-title":"J. Am. Osteopath. Assoc."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0378-8741(89)90053-6","article-title":"Ethnopharmacology of kratom and the Mitragyna alkaloids","volume":"25","author":"Shellard","year":"1989","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/0091415015574184","article-title":"The behavioral risk factor surveillance system","volume":"79","author":"Silva","year":"2014","journal-title":"Int. J. Aging Hum. Dev."},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0085","first-page":"13","article-title":"Kratom in Thailand: decriminalisation and community control?","author":"Tanguay","year":"2011","journal-title":"Ser. Legis. Reform Drug Policies"},{"key":"10.1016\/j.drugalcdep.2017.03.007_bib0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00414-015-1279-y","article-title":"The pharmacology and toxicology of kratom: from traditional herb to drug of abuse","volume":"130","author":"Warner","year":"2016","journal-title":"Int. J. Leg. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617301825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617301825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T12:22:31Z","timestamp":1582546951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617301825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":18,"alternative-id":["S0376871617301825"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.03.007","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Kratom use and health impact in the US\u2014Results from an online survey","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}